Risklick Develops Tool to Speed Up Medical Device Development
Risklick has launched Protocol AI, an AI-based solution to streamline clinical trial development for medical devices.
Risklick has launched Protocol AI, an AI-based solution to streamline clinical trial development for medical devices.
A new survey found that fewer than 3% of pre-market medical device companies are very effective at measuring the results of quality initiatives.
Personalized, non-invasive, lightweight, and portable therapeutic medical devices are an emerging growth market trend, finds Frost & Sullivan.
Risklick has launched Protocol AI, an AI-based solution to streamline clinical trial development for medical devices.